Blockchain-Mediated Clinical-Genetic Data Harmonization for Cohort Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing systems face challenges in integrating clinical and genetic data for precision medicine due to their distinct data types and privacy and data ownership issues, leading to missed opportunities without a unified and secure data-sharing framework.
Innovation Solution
A blockchain platform with specific data structures harmonizes clinical and genetic data, enabling secure, decentralized storage and querying, allowing for cohort creation and genotype-phenotype queries, with user control over data usage and access logs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If clinical and genetic data are stored in separate systems, then data privacy and ownership are maintained, but data interoperability and integration capability deteriorate
Solution Approach 1:
A blockchain-based intermediary layer is introduced between clinical and genetic data systems. This blockchain platform stores harmonized data structures and mapping relationships without consolidating actual patient data, enabling cross-system queries and integration while preserving the autonomy and privacy controls of individual data systems.
Solution Approach 2:
The system segments data management into distinct layers: clinical data remains in clinical systems, genetic data remains in genetic systems, and the blockchain contains segmented harmonization metadata including mapping streams, cohort definitions, and relationship mappings that enable integration without data consolidation.
2Adaptability or versatility
If clinical and genetic data are integrated in a unified system, then data interoperability and analysis capability are improved, but system complexity and security risks increase
Solution Approach 1:
The blockchain acts as a simplified intermediary that manages integration complexity through standardized data structures and mapping streams, preventing the complexity from propagating to both clinical and genetic systems while enabling sophisticated cohort creation and relationship analysis.
Solution Approach 2:
The system implements homogeneous data structures on the blockchain, including standardized cohort definitions, uniform mapping stream formats, and consistent relationship representations, which simplify the integration process and reduce system complexity compared to handling heterogeneous data formats.
3Productivity
If large sample sizes are aggregated for precision medicine analysis, then statistical power is increased, but data security and patient privacy concerns are amplified
Solution Approach 1:
The blockchain intermediary enables aggregation of large cohorts for statistical analysis while maintaining privacy through cryptographic techniques and controlled access. Researchers can query harmonized data structures to create large cohorts for precision medicine studies without direct access to underlying patient-level data, reducing security and privacy risks.
Solution Approach 2:
The system creates cryptographic copies and representations of data relationships on the blockchain rather than storing actual patient data. Mapping streams and cohort definitions are copied representations that enable statistical analysis of large samples while the original sensitive data remains protected in its source systems.
Data Source
AI summary
A method for practicing precision medicine comprising providing, to a blockchain platform, each of clinical data and genetic data, providing the blockchain platform, the blockchain platform having a first data structure comprising clinical data and a second data structure comprising genetic data, harmonizing the first and second data structures, creating at least one cohort based on the harmonized first and second data structures, and identifying at least one relationship between the clinical data and the genetic data in each of the at least one cohort.